Lakeland, FL -- (SBWIRE) -- 10/07/2013 -- Penny Stock Divas is composed of a team of market professionals consisting of research analysts, technical chartists and traders. With over 50 years of combined experience, we work diligently to provide you with accurate information on our best penny stock picks. Here Penny Stock Divas brings a special report on: Elite Pharmaceuticals Inc (OTCBB:ELTP), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Destiny Media Technologies Inc (OTCMKTS:DSNY), Geron Corporation (NASDAQ:GERN)
Elite Pharmaceuticals Inc (OTCBB:ELTP) ended higher +7.23% and complete the day at $0.139. The total number of shares changed hands during the day was 2.77 million. After opening at $0.13, the stock hit as high as $0.14. However, it traded between $0.05 and $0.17 over the last twelve months. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products.
For How Long ELTP will Fight for Profitability? Read This Trend Analysis report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) closed yesterday at $4.56, a +5.07% increase. Around 1.73 million shares were traded, beating an-average trading volume of 4.01 million shares. The company is now valued at around $663.34 million. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
For How Long AVNR’s Gloss will Attract Investors? Find out via this report
Destiny Media Technologies Inc (OTCMKTS:DSNY) moved -8.16 percent higher at $2.25 and traded between $2.20 and $2.41 after opening the day at $2.37. Its performance over the last five days remained +7.14%, which stands at +7314% for a month. Going back further than one month, 1-year performance after recent close was +262.9%. Destiny Media Technologies Inc., through its subsidiaries, engages in the development and marketing of digital media software and solutions principally in the United States, Europe, and Australia. Its solutions and technologies allow the distribution of digital media files through the Internet either in a streaming or digital download format.
Why Should Investors Buy DSNY After the Recent Fall? Just Go Here and Find Out
Geron Corporation (NASDAQ:GERN)’s shares rose, +5.68 percent to close at $3.35. The stock is up around +137.59% this year and +137.59% for the last 12 months. Around 1.72 million shares changed hands yesterday, lower from an-average trading volume of 2.02 million shares. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Why Should Investors Buy GERN After The Recent Gain? Just Go Here and Find Out
About Rocking Penny Stocks
At Rocking Penny Stocks, we focus on discovering stocks with substantial growth potential. We search for microcap stocks able to generate aggressive short and long term gains when driven by time sensitive news and events. Now you might be asking what it is that makes microcap stocks rise in value so quickly. It is almost always because of positive news announcements about the company. Get the hottest microcap stock alerts, news, and information right here! Join our free Penny Stock newsletter.
The assembled information disseminated by rockingpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Rockingpennystocks.com does not expect that investors will buy and sell securities based on information assembled and presented in Rockingpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)